Saturday, 21 October 2017
An IIT solution to 'expensive' biotechnology
When 30-year-old HR professional Rekha Verma (name changed) was diagnosed with breast cancer in 2012, she couldn’t afford ‘wonder drug’ trastuzumab. She prayed that surgery, chemotherapy and radiotherapy would be enough.
You can read more here: An IIT solution to 'expensive' biotechnology
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment